UBE2T and central nervous system cancer: Taken together, these results demonstrated that BA inhibited MAPK/ERK signalling, thereby lowering UBE2T levels, preventing FA pathway activation, and ultimately enhancing the cytotoxic response of glioma tumours to cisplatin in vivo (Figure 6).